Hints and tips:
Related Special Reports
...Temasek’s interest in OpenAI reflects its increasing global footprint over the past decade....
...Concerns about the capacity of Britain’s health service to drive innovation have sharpened since global pharma giant Novartis recently scrapped a major trial of a new drug to reduce cholesterol....
...Backers, who also include Japan’s SoftBank and US private equity firm Tiger Global, will offload part of their stakes in the sale....
...And it also expanded its portfolio of global regulatory licences, while achieving a record high average deposit per active customer....
...Last week, though, marked an exception, as the EU and UK made major strides on the thorny area of clearing....
...“The global economy is still quite fragile. Geopolitical tensions are high, showing no signs of easing....
...Once it gets into its stride, however, Death in the Blood becomes a gripping narrative, strengthened by Wheeler’s longstanding connection to the story....
...Undoubtedly, the US electric vehicle maker, which celebrated its 20th anniversary this year, has made major strides towards this goal....
...“Can you run a growing bank while growing a global offering on a software basis? It requires different management approaches,” said the digital bank executive....
...Public documents filed at Singapore’s corporate registry show Poxdo PTE Ltd was established in May 2020 and name two directors: Lee Ming Chung, a citizen of Singapore, and Nguyen Dac Manh of Ha Noi, Vietnam...
...“In the end, science won the day back then,” said Ken Takeshita, global head of R&D at Daiichi....
...Big pharma companies distribute medicines and products on a global scale but develop fewer drugs themselves, meaning they invest heavily in biotech to secure their drug pipeline....
...seeks to strike out Mozambique ‘tuna bonds’ case (FT) Sanjeev Gupta’s Australian steel business tests bond investor interest (FT) Croatian government pressed Allianz over €500mn Sberbank deal (FT) Big Pharma...
...The company is now considering a global rollout....
...So far this year, venture capital deals in south-east Asia stood at 1,030 through September — up 24 per cent over the same period a year ago — bucking a global 5 per cent decline, according to Preqin....
...Kevin Gorman, senior vice-president at German pharma giant Merck, a key supplier to the chip industry, says the company’s scientists have been working on PFAS-free alternatives since 2020....
...The head of pharma company Sanofi said UK economic policy meant the country was falling behind in healthcare innovation....
...It caused an estimated $10bn in damages and years of wrangling between companies like pharma group Merck and snack maker Mondelez and their insurers....
...“Against these global uncertainties, our investment approach remains cautious,” said Lim Ming Pey, managing director of Temasek’s strategy office, highlighting the impact of the war in Ukraine, slowing economic...
...A key differentiating factor between these groups and Fosun issubsidiary Fosun Pharma....
...He will hold that position together with Paul Russo, the firm’s current global head of equities risk....
...WEBUTECH PTE....
...Although antibiotics fuelled the growth of Big Pharma last century, the industry has retreated since. Many small innovators have collapsed....
...Reliance has recently invested in healthcare companies including genetics group Strand Life Sciences, after buying a majority stake in pharma sales company Netmeds in 2020....
...Even if global supply chain disruptions normalise earlier than expected, investors have a fallback....
International Edition